UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Cannabidiol as a potential treatment for psychosis

Therapeutic Advances in Psychopharmacology, 2019, Vol.9, p.2045125319881916

2019

Volltextzugriff (PDF)

Dysconnectivity of Large-Scale Functional Networks in Early Psychosis: A Meta-analysis

Schizophrenia bulletin, 2019-04, Vol.45 (3), p.579-590

2019

Volltextzugriff (PDF)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders

Journal of Psychopharmacology, 2018-08, Vol.32 (8), p.825-849

2018

Volltextzugriff (PDF)

Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

PLoS medicine, 2021-03, Vol.18 (3), p.e1003524

2021

Volltextzugriff (PDF)

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

Psychiatry research, 2015-01, Vol.225 (1), p.14-30

2015

Volltextzugriff (PDF)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

Molecular psychiatry, 2020-12, Vol.25 (12), p.3231-3240

2020

Volltextzugriff (PDF)

Cannabinoids, reward processing, and psychosis

Psychopharmacology, 2022-05, Vol.239 (5), p.1157-1177

2022

Volltextzugriff (PDF)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Frontiers in psychology, 2020-05, Vol.11, p.833-833

2020

Volltextzugriff (PDF)

Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use

Psychopharmacology, 2021-05, Vol.238 (5), p.1315-1331

2021

Volltextzugriff (PDF)

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence

Frontiers in psychiatry, 2020-08, Vol.11, p.859-859

2020

Volltextzugriff (PDF)

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings

PloS one, 2013-02, Vol.8 (2), p.e55821

2013

Volltextzugriff (PDF)

Cannabidiol modulation of hippocampal glutamate in early psychosis

Journal of psychopharmacology (Oxford), 2021-07, Vol.35 (7), p.814-822

2021

Volltextzugriff (PDF)

Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis

The Lancet. Psychiatry, 2016-03, Vol.3 (3), p.215-225

2016

Volltextzugriff (PDF)

Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort

Biological psychiatry (1969), 2013-07, Vol.74 (2), p.106-112

2013

Volltextzugriff (PDF)

Cannabis use and the development of tolerance: a systematic review of human evidence

Neuroscience and biobehavioral reviews, 2018-10, Vol.93, p.1-25

2018

Volltextzugriff (PDF)

Alterations in White Matter Evident Before the Onset of Psychosis

Schizophrenia bulletin, 2012-11, Vol.38 (6), p.1170-1179

2012

Volltextzugriff (PDF)

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

Frontiers in psychiatry, 2023-07, Vol.14, p.1231710-1231710

2023

Volltextzugriff (PDF)

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

Translational psychiatry, 2020-09, Vol.10 (1), p.311-311, Article 311

2020

Volltextzugriff (PDF)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations

Brain sciences, 2020-02, Vol.10 (2), p.102

2020

Volltextzugriff (PDF)

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report

European archives of psychiatry and clinical neuroscience, 2022-04, Vol.272 (3), p.461-475

2022

Volltextzugriff (PDF)

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior

Brain sciences, 2020-11, Vol.10 (11), p.1

2020

Volltextzugriff (PDF)

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

Brain sciences, 2022-01, Vol.12 (1), p.101

2022

Volltextzugriff (PDF)

Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies

Current pharmaceutical design, 2014, Vol.20 (13), p.2114

2014

Volltextzugriff (PDF)

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5131

2012

Volltextzugriff (PDF)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry

Frontiers in psychiatry, 2021-10, Vol.12, p.771442-771442

2021

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cannabidiol as a potential treatment for psychosis

Dysconnectivity of Large-Scale Functional Networks in Early Psychosis: A Meta-analysis

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders

Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis

Cannabinoids, reward processing, and psychosis

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings

Cannabidiol modulation of hippocampal glutamate in early psychosis

Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis

Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort

Cannabis use and the development of tolerance: a systematic review of human evidence

Alterations in White Matter Evident Before the Onset of Psychosis

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry

Suchergebnisse filtern